Literature DB >> 21674396

Effect of robot-assisted versus conventional body-weight-supported treadmill training on quality of life for people with multiple sclerosis.

Lauren M Wier1, Mary S Hatcher, Elizabeth W Triche, Albert C Lo.   

Abstract

This study describes the effect of body-weight-supported treadmill training (BWSTT) on quality of life (QoL) for multiple sclerosis (MS) patients. Thirteen individuals with MS and gait impairment randomly received two blocks of six biweekly training sessions: (1) robot-assisted BWSTT then BWSTT alone (R-T) or (2) BWSTT alone then robot-assisted BWSTT (T-R). No statistically significant differences were found between robot-assisted BWSTT and unassisted BWSTT for improving QoL outcome measures. The change in Physical Component Summary scores from baseline to the end of the 12 training sessions improved significantly more in the R-T than the T-R group. Within-participant longitudinal changes in QoL for all participants from both groups combined showed significant improvements in 5 of the 13 QoL measures. The results of this pilot study suggest that both types of BWSTT may improve QoL for people with gait dysfunction secondary to MS.

Entities:  

Mesh:

Year:  2011        PMID: 21674396     DOI: 10.1682/jrrd.2010.03.0035

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  14 in total

Review 1.  Rehabilitation interventions in multiple sclerosis: an overview.

Authors:  Serafin Beer; Fary Khan; Jürg Kesselring
Journal:  J Neurol       Date:  2012-07-08       Impact factor: 4.849

Review 2.  The benefits of exercise training in multiple sclerosis.

Authors:  Robert W Motl; Lara A Pilutti
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

3.  Effect of Comorbidities on Outcomes of Neurorehabilitation Interventions in Multiple Sclerosis: A Scoping Review.

Authors:  Afolasade Fakolade; Etienne J Bisson; Julie Pétrin; Julie Lamarre; Marcia Finlayson
Journal:  Int J MS Care       Date:  2016 Nov-Dec

4.  Exercise Training in Progressive Multiple Sclerosis: A Comparison of Recumbent Stepping and Body Weight-Supported Treadmill Training.

Authors:  Lara A Pilutti; John E Paulseth; Carin Dove; Shucui Jiang; Michel P Rathbone; Audrey L Hicks
Journal:  Int J MS Care       Date:  2016 Sep-Oct

5.  Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.

Authors:  Deborah A Hall; Joan A O'keefe
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-05-11

Review 6.  Exercise therapy for fatigue in multiple sclerosis.

Authors:  Martin Heine; Ingrid van de Port; Marc B Rietberg; Erwin E H van Wegen; Gert Kwakkel
Journal:  Cochrane Database Syst Rev       Date:  2015-09-11

7.  Rehabilitation in multiple sclerosis: Commentary on the recent AAN systematic review.

Authors:  Matthew H Sutliff; Susan E Bennett; Patricia Bobryk; June Halper; Lori A Saslow; Lisa T Skutnik; Christine Smith; Kathleen Zackowski; David E Jones
Journal:  Neurol Clin Pract       Date:  2016-12

8.  The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): study protocol for a randomized controlled trial.

Authors:  Sofia Straudi; Fabio Manfredini; Nicola Lamberti; Paolo Zamboni; Francesco Bernardi; Giovanna Marchetti; Paolo Pinton; Massimo Bonora; Paola Secchiero; Veronica Tisato; Stefano Volpato; Nino Basaglia
Journal:  Trials       Date:  2017-02-27       Impact factor: 2.279

9.  Psychometric properties of modified MOS social support survey 5-item (MSSS-5-item) among Iranian older adults.

Authors:  Maryam Bakhshandeh Bavarsad; Mahshid Foroughan; Nasibeh Zanjari; Zahra Jorjoran Shushtari; Gholamreza Ghaedamini Harouni
Journal:  BMC Geriatr       Date:  2021-07-02       Impact factor: 3.921

Review 10.  Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations.

Authors:  Farzin Halabchi; Zahra Alizadeh; Mohammad Ali Sahraian; Maryam Abolhasani
Journal:  BMC Neurol       Date:  2017-09-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.